These literatures not only suggested that high circulating FGF21 were adaptive increase in response to metabolic disturbances, but also implied that monitoring serum FGF21 levels may serve as an effective target for managing CAD in men with T2DM. The gene discussed is FGF21; the disease is type 2 diabetes mellitus.